| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.23(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,226,422 |
| 52
Week Range: |
$6.13 - $10.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
6,313 |
13,261 |
14,828 |
| Total Sell Value |
$0 |
$61,867 |
$119,170 |
$133,715 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
1 |
4 |
7 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Valueact Holdings Gp, Llc |
See Remarks |
– • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,037 |
21,046 |
|
- |
|
| Paulson John |
Director |
• • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,037 |
68,523 |
|
- |
|
| Von Eschenbach Andrew C. |
Director |
• • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,037 |
29,602 |
|
- |
|
| Ross Thomas W. Sr. |
Director |
• • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,037 |
90,279 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,037 |
291,679 |
|
- |
|
| Valueact Holdings Gp, Llc |
See Remarks |
– • – |
2020-04-29 |
4 |
D |
$18.11 |
$11,301 |
D/D |
(624) |
10,009 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2020-04-29 |
4 |
D |
$18.11 |
$11,301 |
D/D |
(624) |
280,642 |
|
- |
|
| Robertson Russel C |
Director |
• • – |
2020-03-31 |
4 |
A |
$15.50 |
$37,495 |
D/D |
2,419 |
96,402 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2020-03-31 |
4 |
A |
$15.50 |
$6,867 |
D/D |
443 |
89,317 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2020-03-31 |
4 |
A |
$15.50 |
$31,248 |
D/D |
2,016 |
281,266 |
|
- |
|
| Paulson John |
Director |
• • – |
2020-03-31 |
4 |
A |
$15.50 |
$27,497 |
D/D |
1,774 |
57,486 |
|
- |
|
| Ross Thomas W. Sr. |
Director |
• • – |
2020-03-12 |
4 |
B |
$15.54 |
$38,838 |
D/D |
2,500 |
79,242 |
2.39 |
7% |
|
| De Schutter Richard U |
Director |
• • – |
2020-03-10 |
4 |
B |
$18.26 |
$69,377 |
I/I |
3,800 |
13,800 |
2.1 |
-8% |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,390 |
96,025 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2020-03-10 |
4 |
B |
$18.25 |
$80,106 |
D/D |
4,390 |
91,635 |
2.74 |
-8% |
|
| Von Eschenbach Andrew C. |
Director |
• • – |
2020-03-10 |
4 |
B |
$18.18 |
$19,996 |
D/D |
1,100 |
18,565 |
2.39 |
-8% |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2020-03-09 |
4 |
D |
$20.96 |
$195,515 |
D/D |
(9,328) |
300,253 |
|
- |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2020-03-09 |
4 |
D |
$20.96 |
$387,508 |
D/D |
(18,488) |
904,092 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2020-03-09 |
4 |
D |
$20.96 |
$46,929 |
D/D |
(2,239) |
79,563 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2020-03-09 |
4 |
D |
$20.96 |
$36,659 |
D/D |
(1,749) |
81,052 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2020-03-09 |
4 |
D |
$20.96 |
$70,069 |
D/D |
(3,343) |
87,245 |
|
- |
|
| Appio Thomas |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2020-03-09 |
4 |
D |
$20.96 |
$57,305 |
D/D |
(2,734) |
186,635 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2020-03-03 |
4 |
B |
$23.08 |
$115,415 |
D/D |
5,000 |
279,250 |
2.39 |
-24% |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2020-03-02 |
4 |
D |
$22.52 |
$110,911 |
D/D |
(4,925) |
922,580 |
|
- |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2020-02-28 |
4 |
D |
$24.44 |
$226,534 |
D/D |
(9,269) |
927,505 |
|
- |
|
705 Records found
|
|
Page 12 of 29 |
|
|
0.08 (1.29%) 
